Although SALL4 has been reported as a prognosis-related biomarker for many cancers, such as liver cancer, esophageal cancer, germ cell cancer, and breast cancer (Cao et al., 2009a; Liu T.-C. Here, SALL4 is linked to esophageal cancer.